Company intelligence

BWAY

BrainsWay Ltd. · NASDAQ · Healthcare

Price$14.43+1.69% · +$0.24

Market cap565.99MEquity value

P / E36.7Trailing ratio

Volume56.59KLatest session

Market data

BWAY price chart

TradingView

Related signals

1 min delayed

Browse public BWAY signals with their source context and measured market impact. Open any signal for its permanent analysis page.

BWAYMar 11, 2026+7.75% since signal

BrainsWay Reports Strong Q4 and 2025 Financial Results with Positive Outlook

BrainsWay Ltd. reported a 27% year-over-year revenue increase to $14.5 million in Q4 2025, alongside a 161% surge in net income to $7.6 million. The company anticipates a favorable growth trajectory due to recent FDA approvals and an increased performance obligation of around $70 million.

View signal analysis

BWAYJul 25, 2024+9.34% since signal

Strength Seen in Brainsway (BWAY): Can Its 9.3% Jump Turn into More Strength?

BWAY shares rose 9.3% to $7.28 amid high trading volume. The stock's price increase reflects positive investor sentiment before Q2 earnings report. BWAY forecasts break-even earnings per share with 20.1% revenue growth expected. Consensus EPS estimates remain unchanged, indicating stable price outlook. BWAY holds a Zacks Rank #3, suggesting a neutral market position.

View signal analysis

Research